Adalimumab is biological drug for patients suffering from rheumatoid arthritis (RA), which affects around 1% of the world population. By measuring the concentrations of adalimumab, it is possible to enhance the management of the disease in a more efficient and effective manner.
Click here to learn more about the team of 2019!